Literature DB >> 18616477

Blood culture isolates and antimicrobial sensitivities from 427 critically ill neonatal foals.

C M Russell1, J E Axon, A Blishen, A P Begg.   

Abstract

OBJECTIVE: To assist correct decision-making about antimicrobial treatment of equine neonates with septicaemia.
DESIGN: Retrospective study of microbial blood culture results obtained from foals less than 7 days of age.
METHODS: Microbial blood culture results from foals less than 7 days of age admitted to an intensive care unit between July 1999 and December 2004 were reviewed. Antimicrobial sensitivity was assessed by the Kirby Bauer disc diffusion method. Antimicrobials were defined as an effective first-line choice antimicrobial if greater than 70% of isolates were susceptible. Multiple drug resistance (MDR) was defined as resistance to at least three antimicrobials in different chemical classes or with different mechanisms of resistance.
RESULTS: Of the 427 Thoroughbred foals included in the study, a positive blood culture was obtained in 110 foals and 124 microorganisms were isolated. Gram-positive isolates, predominantly Streptococcus/Enterococcus spp, were obtained in 41% of foals. Gram-negative isolates were predominantly of the Enterobacteriaceae family, in particular Escherichia coli. The overall antimicrobial sensitivity of the isolates was low. The Gram-positive organisms had unpredictable sensitivity patterns. MDR was recorded in 32% of isolates. In total, 81% of foals were discharged from hospital and 74.5% of foals with a positive blood culture were discharged.
CONCLUSION: With the increasing prevalence of Gram-positive microorganisms and their unpredictable sensitivity patterns, blood cultures remain important in the diagnosis and treatment of equine neonatal septicaemia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18616477     DOI: 10.1111/j.1751-0813.2008.00311.x

Source DB:  PubMed          Journal:  Aust Vet J        ISSN: 0005-0423            Impact factor:   1.281


  8 in total

1.  Antimicrobial resistance in bacteria isolated from horses from the Atlantic Provinces, Canada (1994 to 2013).

Authors:  Babafela B Awosile; Luke C Heider; Matthew E Saab; J T McClure
Journal:  Can Vet J       Date:  2018-09       Impact factor: 1.008

2.  Plasma Peak and Trough Gentamicin Concentrations in Hospitalized Horses Receiving Intravenously Administered Gentamicin.

Authors:  J R Bauquier; R C Boston; R W Sweeney; P A Wilkins; R D Nolen-Walston
Journal:  J Vet Intern Med       Date:  2015-10-01       Impact factor: 3.333

3.  An epidemiologic study of antimicrobial resistance of Staphylococcus species isolated from equine samples submitted to a diagnostic laboratory.

Authors:  Ronita Adams; Jackie Smith; Stephen Locke; Erica Phillips; Erdal Erol; Craig Carter; Agricola Odoi
Journal:  BMC Vet Res       Date:  2018-02-05       Impact factor: 2.741

4.  Pattern recognition receptors in equine endotoxaemia and sepsis.

Authors:  A H Werners; C E Bryant
Journal:  Equine Vet J       Date:  2012-05-20       Impact factor: 2.888

Review 5.  A review of equine sepsis.

Authors:  S Taylor
Journal:  Equine Vet Educ       Date:  2015-01-14       Impact factor: 1.063

6.  Differences in isolation rate and antimicrobial susceptibility of bacteria isolated from foals with sepsis at admission and after ≥48 hours of hospitalization.

Authors:  Mathijs J P Theelen; W David Wilson; Barbara A Byrne; Judy M Edman; Philip H Kass; Lapo Mughini-Gras; K Gary Magdesian
Journal:  J Vet Intern Med       Date:  2020-02-05       Impact factor: 3.333

7.  Factors associated with the risk of positive blood culture in neonatal foals presented to a referral center (2000-2014).

Authors:  Martin Furr; Harold McKenzie
Journal:  J Vet Intern Med       Date:  2020-10-12       Impact factor: 3.333

8.  Evaluation of updated sepsis scoring systems and systemic inflammatory response syndrome criteria and their association with sepsis in equine neonates.

Authors:  D M Wong; R E Ruby; K A Dembek; B S Barr; S M Reuss; K G Magdesian; E Olsen; T Burns; N M Slovis; P A Wilkins
Journal:  J Vet Intern Med       Date:  2018-03-26       Impact factor: 3.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.